env 105
Generic: carotuximab
env 105: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Kairos Pharma, LTD. (KAPA) | Phase 2 |
Get deeper analysis on env 105
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis